Explore
Validate
Learn
ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN559682 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN559682, RRID:AB_10773244
- Product name
- anti-Membrane-Spanning 4-Domains, Subfamily A, Member 1 (MS4A1) antibody
- Antibody type
- Monoclonal
- Antigen
- Human tonsillar B cells
- Reactivity
- Human
- Isotype
- IgG
- Antibody clone number
- 2H7
- Vial size
- 100 tests
- Storage
- 4°C
Submitted references CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells.
STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.
CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts.
A cholesterol-dependent CD20 epitope detected by the FMC7 antibody.
Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.
Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure.
Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20.
Hayden-Ledbetter MS, Cerveny CG, Espling E, Brady WA, Grosmaire LS, Tan P, Bader R, Slater S, Nilsson CA, Barone DS, Simon A, Bradley C, Thompson PA, Wahl AF, Ledbetter JA
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Apr 15;15(8):2739-46
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Apr 15;15(8):2739-46
STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.
Diehl SA, Schmidlin H, Nagasawa M, van Haren SD, Kwakkenbos MJ, Yasuda E, Beaumont T, Scheeren FA, Spits H
Journal of immunology (Baltimore, Md. : 1950) 2008 Apr 1;180(7):4805-15
Journal of immunology (Baltimore, Md. : 1950) 2008 Apr 1;180(7):4805-15
CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts.
Chan HT, Hughes D, French RR, Tutt AL, Walshe CA, Teeling JL, Glennie MJ, Cragg MS
Cancer research 2003 Sep 1;63(17):5480-9
Cancer research 2003 Sep 1;63(17):5480-9
A cholesterol-dependent CD20 epitope detected by the FMC7 antibody.
Polyak MJ, Ayer LM, Szczepek AJ, Deans JP
Leukemia 2003 Jul;17(7):1384-9
Leukemia 2003 Jul;17(7):1384-9
Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.
Rose AL, Smith BE, Maloney DG
Blood 2002 Sep 1;100(5):1765-73
Blood 2002 Sep 1;100(5):1765-73
Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure.
Polyak MJ, Deans JP
Blood 2002 May 1;99(9):3256-62
Blood 2002 May 1;99(9):3256-62
Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20.
Deans JP, Kalt L, Ledbetter JA, Schieven GL, Bolen JB, Johnson P
The Journal of biological chemistry 1995 Sep 22;270(38):22632-8
The Journal of biological chemistry 1995 Sep 22;270(38):22632-8
No comments: Submit comment
No validations: Submit validation data